Wednesday, 11 November 2026 Clear skyNew Delhi 27° New DelhiLondonNew YorkDubaiTokyo
INDEPENDENT THINKING.
SHARED UNDERSTANDING.International edition · Correspondents across India and around the world
RationalTimes●
A little less noise.
A little more perspective. Join our media house
BREAKING
VerifiedAndhra Pradesh converts investment projects worth ₹17.2 lakh crore ahead of Vizag CII Summit Verified3 CRPF Personnel Injured In Terrorist Attack In Kashmir's Kulgam VerifiedIIT Madras Pravartak Launches Free Online Future-Ready Skill Courses For Class 7–12 Students VerifiedCongress launches ‘Punjab Mangda Insaaf’ campaign ahead of State polls VerifiedIsraeli Tourist Pushes Sri Lankan Tour Guide Into Sea, Video Sparks Outrage ClimateCOP31 climate talks open in Antalya, Türkiye, on 9 November USAmericans vote in the midterm elections on 3 November TechnologyNorth Korea-linked hackers steal about $6.4 billion from Binance in the biggest crypto theft on record, analysts say WorldSpain mourns after a high-speed train ploughs into a stationary train near Toledo, killing at least 68 WorldIsrael’s election ends without a clear winner as exit polls leave both blocs short of a majority WorldSaudi Arabia intercepts Houthi missiles and drones as Egypt’s parliament backs military support PoliticsLula wins Brazil’s presidential runoff as Flávio Bolsonaro concedes
Developing · 1 outletHealth

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

Headline via STAT · first report 10 Nov, 19:08 IST, latest 10 Nov, 19:08 IST

All India Institute of Medical Sciences, New Delhi
Representational image · All India Institute of Medical Sciences, New Delhi · Baap8969 / Wikimedia Commons, CC0

What we know

So far only STAT has reported this (10 Nov, 19:08 IST). It will be marked Verified when a second, independent news organisation reports it. Rational Times has not independently confirmed the details: read each report through the links below.

StatusDeveloping
Reported by1 news organisation
First report10 Nov, 19:08 IST
Latest report10 Nov, 19:08 IST
DeskHealth

What the reports sayEach newsroom’s own summary of its report, from its feed

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.

About NetherlandsEuropeHealth 10 Nov 2026

The reports1 report

Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake

Read nextThe biggest stories right now